Teratogenic Evaluation of Metronidazole and Ornidazole Using Drosophila melanogaster as an Experimental Model

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 4, 2004, Pages 157-162

  Palermo, Ana María ^a,b   Reynoso, A S ^a   Lopez Nigro M ^b   Carballo, M A ^b   Mudry, M D ^b  

^a Instituto de Investigaciones Cientificas y Tecnicas de Las Fuerzas Armadas   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; ORNIDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVELOPING COUNTRY; DEVELOPMENTAL BIOLOGY; DEVELOPMENTAL DISORDER; DROSOPHILA MELANOGASTER; EVALUATION; EXPERIMENTAL MODEL; FEMALE; INCIDENCE; LARVAL DEVELOPMENT; MORPHOLOGICAL TRAIT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TERATOGENICITY; TOXICITY TESTING; VERTEBRATE; WILD TYPE;

ABDOMEN; ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTIPROTOZOAL AGENTS; DROSOPHILA MELANOGASTER; LARVA; METRONIDAZOLE; ORNIDAZOLE; THORAX;

DROSOPHILA MELANOGASTER; MELANOGASTER; VERTEBRATA;

EID: 2342466701     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20008     Document Type: Article

References (26)

1. Bone W, Yeung CH, Skupin R, et al. 1997. Toxicity of ornidazole and its analogues to rat spermatozoa as reflected in motility parameters. Int J Androl 20:347-355.
2. Bourget P, Dechelette N, Fernandez H, Desmaris VQ. 1995. Disposition of ornidazole and its metabolites during pregnancy. J Antimicrob Chemother 35:691-696.
3. Bournias-Vardiabasis N, Teplitz RL, Chernoff GF, Seecof RL. 1983. Detection of teratogens in the Drosophila embryonic cell culture test: assay of 100 chemicals. Teratology 28:109-122.
4. Carballo MA, Palermo AM, López Nigro M, et al. 2001. Mutagenicidad química y evaluación de daño potencial mediante ensayos de corto plazo (ECT). Acta Toxicol Argent 9:4-8.
5. Cooper TG, Yeung Ch-H, Skupin R, Haufe G. 1997. Antifertility potential of ornidazole analogues in rats. J Androl 18:431-438.
6. Czeizel AE, Rockenbauer M. 1998. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 105:322-327.
7. Diav-Citrin O, Gotteiner T, Shechtman S, et al. 2000. Pregnancy outcome following gestational exposure to metronidazole: a prospective controlled cohort study. Teratology 61:440.
8. Dobiáš L, Černá M, Rössner P, Šrám R. 1994. Genotoxicity and carcinogenicity of metronidazole. Mutat Res 317:177-194.
9. Ivanov I. 1969. The effect of "Trichomonacid" on pregnancy in experimental animals. Akusherstvo, Gynecology 8:241-244.
10. Linder RE, Strader LF, Slott VL, Suarez JD. 1992. Endpoints of spermatotoxicity in the rat after short duration exposures to fourteen reproductive toxicants. Reprod Toxicol 6:491-505.
11. López Nigro M, Palermo AM, Mudry MD, Carballo MA. 2003. Cytogenetic evaluation of two nitroimidazole derivatives. Toxicol in Vitro 17:35-40.
12. Lynch DW, Schuler RL, Hood RD and DG Davis. 1991. Evaluation for Drosophila for Screening Developmental Toxicants: Test Results with Eighteen Chemicals and Presentation of a New Drosophila Bioassay. Teratog Carcinog Mutagen 11:147-173.
13. McClain RM, Downing JC. 1988. Reproduction studies in rats treated with Ornidazole. Toxicol Appl Pharmacol 92:480-487.
14. Morgan IFK. 1979. Metronidazole treatment in pregnancy. In: Phillips I, Collier J, editors. Metronidazole. Proceedings, Geneva, April 25-27. New York: Academic Press. pp 229-235.
15. Mudry MD, Carballo M, Labal de Vinuesa M, et al. 1994. Mutagenic bioassay of certain pharmacological drugs: III Metronidazole (MTZ). Mutat Res 305:127-132.
16. Mudry MD, Gadano A, González M, Carballo M. 1995. Mutagénesis química: Riesgo y beneficio en el consumo de antiparasitarios. Interciencia 20:204-211.
17. Mudry MD, Martinez-Flores I, Palermo AM, et al. 2001. Embryolethality induced by metronidazole (MTZ) in Rattus norvegicus. Teratog Carcinog Mutagen 21:197-205.
18. Petersen NS. 1990. Effects of heath and chemical stress on development. Adv Genet 28:275-296.
19. Piper JM, Mitchel EF, Ray WA. 1993. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 82:348-352.
20. Ranganathan S, Davia DG, Hood RD. 1987. Developmental toxicity of ethanol in Drososphila melanogaster. Teratology 36:45-49.
21. Ricciardi C. 1997. Complex biological systems as experimental and prenatal toxicology models. Ann Ist Super Sanita 33:531-539.
22. Rodriguez FG, Cancino BL, López NM, et al. 2002. DNA single strand breaks in peripheral blood lymphocytes induced by three nitroimidazole derivatives. Toxicol Lett 132:109-115.
23. Roe FJC. 1985. Safety of nitroimidazoles. Scand J Infect Dis 46(suppl):72-81.
24. Schuler RL, Harding BD, Niemeier RW. 1982. Drosophila as a tool for the rapid assessment of chemicals for teratogenicity. Teratog Carcinog Mutagen 2:293-301.
25. Schuller RL, Radike MA, Harding BD, Niemeier RW. 1985. Pattern of response of intact Drosophila to known teratogens. J Am Coll Toxicol 4:291-303.
26. Thapa PB, Whitlock JA, Brockman Worrel KG, et al. 1998. Prenatal exposure to metronidazole and risk of childhood cancer: a retrospective cohort study of children younger than 5 years. Cancer 83:1461-1468.